Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTM2 | P28161 | 1/20 | 0.76 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 6/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MYC | P01106 | 4/20 | 0.53 |
| ▸ | MAX | P61244 | 1/20 | 0.53 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15515612 | 1.00 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL31320442 | 1.00 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL15516469 | 1.00 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL459120 | 1.00 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL592618 | 1.00 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL14617994 | 0.95 | GSTM2 (0.72) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL30892505 | 0.91 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL30892506 | 0.91 | GSTM2 (0.76) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL17525024 | 0.90 | GSTM2 (0.67) | GSTM2HRH3MEN1KMT2AUSP2 | |
| SCHEMBL13524165 | 0.89 | GSTM2 (0.74) | GSTM2HRH3MEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4247968-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | Becton, Dickinson and Company (US) | 2023-09-27 | — | — | EP | claimed |
| US-20220296549-A1 | Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms | NATUREZA, INC. (US) | 2022-09-22 | — | — | US | claimed |
| US-11351134-B2 | Small molecule agents, compositions, and formulations, for internal use, displaying inhibitory activity against gram-positive and/or gram-negative organisms | NATUREZA PRODUCTS, INC. (US) | 2022-06-07 | — | — | US | claimed |
| WO-2022109339-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220064226-A1 | Panel comprising Borrelia MHC multimers | IMMUDEX APS (DK) | 2022-03-03 | — | — | US | claimed |
| EP-3898666-A2 | PANEL COMPRISING BORRELIA MHC MULTIMERS | Immudex ApS (DK) | 2021-10-27 | — | — | EP | claimed |
| WO-2020127222-A2 | PANEL COMPRISING BORRELIA MHC MULTIMERS | IMMUDEX APS (DK) | 2020-06-25 | — | — | WO | claimed |
| EP-3664794-A1 | LAURIC ACID DERIVATIVES DISPLAYING INHIBITORY ACTIVITY AGAINST GRAM-POSITIVE AND/OR GRAM-NEGATIVE ORGANISMS | Natureza, Inc. (US) | 2020-06-17 | — | — | EP | claimed |
| WO-2019033125-A9 | LAURIC ACID DERIVATIVES DISPLAYING INHIBITORY ACTIVITY AGAINST GRAM-POSITIVE AND/OR GRAM-NEGATIVE ORGANISMS | NATUREZA, INC. (US) | 2020-04-02 | — | — | WO | claimed |
| WO-2019033125-A1 | LAURIC ACID DERIVATIVES DISPLAYING INHIBITORY ACTIVITY AGAINST GRAM-POSITIVE AND/OR GRAM-NEGATIVE ORGANISMS | NATUREZA, INC. (US) | 2019-02-14 | — | — | WO | claimed |
| EP-2337795-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | Dako Denmark A/S (DK) | 2011-06-29 | — | — | EP | claimed |
| EP-2254592-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | Dako Denmark A/S (DK) | 2010-12-01 | — | — | EP | claimed |
| EP-2197908-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | Dako Denmark A/S (DK) | 2010-06-23 | — | — | EP | claimed |
| WO-2010037397-A1 | MHC MULTIMERS IN CMV IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | claimed |
| WO-2010037395-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | claimed |
| EP-2155782-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | Dako Denmark A/S (DK) | 2010-02-24 | — | — | EP | claimed |
| WO-2009106073-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | DAKO DENMARK A/S (DK) | 2009-09-03 | — | — | WO | claimed |
| WO-2009039854-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | DAKO DENMARK A/S (DK) | 2009-04-02 | — | — | WO | claimed |
| WO-2008116468-A2 | MHC PEPTIDE COMPLEXES AND USES THEREOF IN INFECTIOUS DISEASES | DAKO DENMARK A/S (DK) | 2008-10-02 | — | — | WO | claimed |
| US-6830919-B1 | For ceramide metabolism/formation of fatty acid and sphingoid; genetic engineering; for treatment of metabolic disorders | TAKARA BIO INC. (JP) | 2004-12-14 | — | — | US | claimed |